- Home
- BSBK vs CLNN Comparison
BSBK vs CLNN Comparison
Compare BSBK & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBK | CLNN |
|---|---|---|
| Founded | 1893 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.1M | 120.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BSBK | CLNN |
|---|---|---|
| Price | $8.36 | $5.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 9.5K | ★ 314.9K |
| Earning Date | 02-13-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $15,989,970.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $92.84 |
| P/E Ratio | $225.03 | ★ N/A |
| Revenue Growth | ★ 31.80 | N/A |
| 52 Week Low | $6.59 | $2.28 |
| 52 Week High | $9.50 | $13.50 |
Technical Indicators
Market Signals| Indicator | BSBK | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | 37.84 |
| Support Level | $8.25 | $5.71 |
| Resistance Level | $8.50 | $6.56 |
| Average True Range (ATR) | 0.12 | 0.53 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 63.92 | 14.72 |
Price Performance
Historical ComparisonAbout BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.